Intrinsic Value of S&P & Nasdaq Contact Us

Enliven Therapeutics, Inc. ELVN

NASDAQ Global Select

SharesGrow Score
44/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$43.33
-3.4%

Enliven Therapeutics, Inc. (ELVN) current share price is $44.85. The gold spot price is $4,825.20 per troy ounce. Using the formula: ELVN in gold = $44.85 × 31.1035 ÷ $4,825.20 = 0.2891 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of ELVN when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding ELVN shares over the measured period.

ELVN in US Dollars
Gold in US Dollars
ELVN in Gold (grams per share)

Real Wealth Growth Rate

ELVN
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{ELVN}_{\text{gold}}(t) = \frac{P_{\text{ELVN}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{ELVN}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{ELVN}_{\text{gold}}^{(T)}}{\text{ELVN}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{ELVN}_\text{gold}^{(0)}$ = initial gold-price, $\text{ELVN}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

CELC
CELC
Celcuity Inc.
$120.85
+0.37%
GPCR
GPCR
Structure Therapeutics Inc.
$53.19
-1.95%
MLTX
MLTX
MoonLake Immunotherapeutics
$18.78
+1.90%
INBX
INBX
Inhibrx Biosciences, Inc.
$83.19
+7.40%
CGEM
CGEM
Cullinan Oncology, Inc.
$14.35
+0.70%
CMPX
CMPX
Compass Therapeutics, Inc.
$5.44
+4.62%
ELYM
ELYM
Eliem Therapeutics, Inc.
$5.11
-0.97%
NVCT
NVCT
Nuvectis Pharma, Inc.
$8.73
+3.19%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message